1. Home
  2. DLB vs RGEN Comparison

DLB vs RGEN Comparison

Compare DLB & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DLB
  • RGEN
  • Stock Information
  • Founded
  • DLB 1965
  • RGEN 1981
  • Country
  • DLB United States
  • RGEN United States
  • Employees
  • DLB N/A
  • RGEN N/A
  • Industry
  • DLB Multi-Sector Companies
  • RGEN Medical/Dental Instruments
  • Sector
  • DLB Miscellaneous
  • RGEN Health Care
  • Exchange
  • DLB Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • DLB 7.9B
  • RGEN 8.0B
  • IPO Year
  • DLB 2005
  • RGEN N/A
  • Fundamental
  • Price
  • DLB $77.57
  • RGEN $126.50
  • Analyst Decision
  • DLB Strong Buy
  • RGEN Buy
  • Analyst Count
  • DLB 4
  • RGEN 12
  • Target Price
  • DLB $101.75
  • RGEN $172.67
  • AVG Volume (30 Days)
  • DLB 400.0K
  • RGEN 815.5K
  • Earning Date
  • DLB 05-01-2025
  • RGEN 04-29-2025
  • Dividend Yield
  • DLB 1.71%
  • RGEN N/A
  • EPS Growth
  • DLB 36.08
  • RGEN N/A
  • EPS
  • DLB 2.64
  • RGEN N/A
  • Revenue
  • DLB $1,320,184,000.00
  • RGEN $650,429,000.00
  • Revenue This Year
  • DLB $6.38
  • RGEN $13.93
  • Revenue Next Year
  • DLB $4.65
  • RGEN $14.35
  • P/E Ratio
  • DLB $29.29
  • RGEN N/A
  • Revenue Growth
  • DLB 4.03
  • RGEN 4.88
  • 52 Week Low
  • DLB $66.35
  • RGEN $102.97
  • 52 Week High
  • DLB $89.66
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • DLB 56.62
  • RGEN 44.61
  • Support Level
  • DLB $76.69
  • RGEN $123.10
  • Resistance Level
  • DLB $78.28
  • RGEN $135.47
  • Average True Range (ATR)
  • DLB 1.39
  • RGEN 6.98
  • MACD
  • DLB 0.47
  • RGEN -0.97
  • Stochastic Oscillator
  • DLB 88.03
  • RGEN 25.20

About DLB Dolby Laboratories

Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company designs and manufactures audio, imaging, accessibility, and other hardware and software solutions for the cinema, with occasional applications in the television, broadcast, and live entertainment industries. The company operates in the United States and internationally.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: